Top Ten Global Pharmaceutical Licensing Deals 2008

  • December 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Top Ten Global Pharmaceutical Licensing Deals 2008 as PDF for free.

More details

  • Words: 112
  • Pages: 1
Rank Company 1 GlaxoSmithKline 2 Genzyme 3 Roche 4 Astellas Pharma 5 Pfizer 6 Bristol-Myers Squibb 7 Merck KGaA 8 GlaxoSmithKline 9 GlaxoSmithKline 10 Nycomed

Deal Type In-licensed In-licensed In-licensed In-licensed In-licensed In-licensed In-licensed

Product Almorexant (ACT-078573) Mipomersen R7334 CTS-21166 Dimebon Elotuzumab Asonep Efflux Pump Inhibitors In-licensed Research Project In-licensed Retigabine In-licensed Veltuzumab (IMMU-106)

Deal Partner/ Product Deal Source Value($m) Actelion 3,009 Isis Pharmaceuticals 1,900 ThromboGenics 750 CoMentis 744 Medivation 725 PDL BioPharma 710 Lpath 696 655 Mpex Pharmaceuticals Valeant Pharmaceuticals 634 Immunomedics 591

Prepared By: ManasRanjanRout Pharmaceutical & Healthcare Professional New Delhi Email: [email protected]

Deal Date J ul-08 J an-08 J un-08 Apr-08 Oct-08 Aug-08 Oct-08 J un-08 Aug-08 J ul

Related Documents